Читать книгу Genetic Analysis of Complex Disease - Группа авторов - Страница 57

1 Bellus, G.A., Hefferon, T.W., Ortiz de Luna, R.I. et al. (1995). Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56: 368–373.

2 Corder, E.H., Saunders, A.M., Risch, N.J. et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7: 180–184.

3 Corder, E.H., Saunders, A.M., Strittmatter, W.J. et al. (1995a). Apolipoprotein E, survival in Alzheimer disease patients and the competing risks of death and Alzheimer disease. Neurology 45: 1323–1328.

4 Corder, E.H., Saunders, A.M., Strittmatter, W.J. et al. (1995b). The apolipoprotein E E4 allele and sex‐specific risk of Alzheimer’s disease [letter; comment]. JAMA 273: 373–374.

5 Cystic Fibrosis Mutation Database. (2011) www.genet.sickkids.on.ca/cftr/ (accessed 3 March 2015)

6 Farrer, L.A., Cupples, L.A., Haines, J.L. et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A metaanalysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349–1356.

7 Friedman, J.M. (1981). Genetic disease in the offspring of older fathers. Obstet. Gynecol. 57 (6): 745–749.

8  Garrod, A.E. (1902). The incidence of alkaptonuria: a study in chemical individuality. Lancet ii: 1616–1620.

9 Hamosh, A., Fitz‐Simmons, S.C., Macek, M. et al. (1998). Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J. Pediatr. 132: 255–259.

10 Hardy, G.H. (1908). Mendelian proportions in a mixed population. Science 28: 41–50.

11 Hoogerwaard, E., van der Wouw, P., Wilde, A. et al. (1999). Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul. Disord. 9: 347–351.

12 Jorde, L.B., Carey, J.C., and White, R.L. (eds.) (1995). Medical Genetics. St. Louis, MO: C. W. Mosby.

13 Koenig, M., Monaco, A.P., and Kunkel, L.M. (1988). The complete sequence of dystrophin predicts a rod‐shaped cytoskeletal protein. Cell 53: 219–228.

14 La Spada, A. and Taylor, J. (2010). Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 11: 247–258.

15 Penrose, L.S. (1955). Parental age and mutation. Lancet ii: 312–313.

16 Pericak‐Vance, M.A. and Haines, J.L. (1995). Genetic susceptilbility to Alzheimer disease. Trends Genet. 11: 504–508.

17 Polak, U., McIvor, E., Dent, S.Y. et al. (2013). Expanded complexity of unstable repeat diseases. Biofactors 39 (2): 164–175.

18 Ratjen, F. and Doring, G. (2003). Cystic fibrosis. Lancet 361 (9358): 681–689.

19 Rousseau, F., Bonaventure, J., Legeai‐Mallet, L. et al. (1994). Mutations in the gene encoding fibroblast growth factor receptor‐3 in achondroplasia. Nature 371: 252–254.

20 Saunders, A.M., Strittmatter, W.J., Schmechel, D. et al. (1993). Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472.

21 Shiang, R., Thompson, L.M., Zhu, Y.‐Z. et al. (1994). Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335–342.

22 Stankiewicz, P. and Lupski, J. (2010). Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61: 437–455.

23 Stoll C, Roth M‐P, Bigel P (1982): A reexamination of parental age effect on the occurrence of new mutations for achondroplasia. Prog. Clin. Biol. Res., 104:419–426.

24 Strachan, T. and Read, A.P. (1996). Human Molecular Genetics, 1ste. New York: Wiley.

25 Takeshima, Y., Yagi, M., Okizuka, Y. et al. (2010). Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J. Hum. Genet. 55: 379–388.

26 Thompson, M.W., McInnes, R.R., Willard, H.F., and Thompson, J.S. (eds.) (1991). Genetics in Medicine, 5the. Philadelphia, PA: W. B. Saunders Company.

27 Tjio, J.H. and Levan, A. (1956). The chromosome number of man. Hereditas 42: 1–6.

28 Turner, G., Webb, T., Wake, S., and Robinson, H. (1996). Prevalence of fragile X syndrome. Am. J. Med. Genet. 64 (1): 196.

29 Watson, J.D. (1968). The Double Helix. New York: Atheneum.

30 Watson, J.D. and Crick, F.H.C. (1953). A structure for deoxyribose nucleic acid. Nature 171: 737–738.

31 Weinberg, W. (1908). Uber den nachweis der vererbung beim Menschen. Jahreshefte des vereins fur vaterlandische naturkunde in wurttemberg. Wurttemberg 64: 368–382.

32 Zarrei, M., MacDonald, J.R., Merico, D., and Scherer, S.W. (2015). A copy number variation map of the human genome. Nat. Rev. Genet. 16 (3): 172–183.